RuiShiZhi druggist novartis reported fourth quarter net profit of $208 million.
The result is 72% in the fourth quarter of 2011 report, Basel company spent $9 million high blood pressure drug Tekturna into wider use, its clinical at the end of the study, more than $1.21 billion in net profit.
Novartis said Wednesday, in the fourth quarter of 2012 sales revenue of $1.478 billion us dollars, compared to the same period last year 1.483 billion dollars, almost flat.
The company also said that, for a long time before the President and CEO Mr Vasella in at the end of February will leave the board of directors at the shareholders' meeting.



Other News:
Poland president says won't enter euro before 2015 ballots
Novartis Q4 net profit rebounds to $2.1 billion
Japan logs record trade gap in 2012 as exports struggle
ECOWAS peacekeeping force 1,000 people arrived in Mali
France say 1,000 African troops are now in Mali
U.S. drone kills six suspected al Qaeda members in Yemen
Top U.S. commander in Afghanistan cleared in Pentagon inquiry
Objection become way of life in Spanish recession